The companies’ joint offering expands on the recent American College of Cardiology guidelines regarding the use of CCTA for non-invasive heart disease evaluation. Heartbeat Health's nationwide team of virtual cardiologists provide better care wherever patients might be. Heartbeat Health offers real-time clinical data and device connectivity to deliver a range of clinical offerings, including same-day diagnostic reads, televisits and care programs. This AI-powered scan provides a more accurate understanding of a patient’s risk of heart attack and improves on historical assessments of heart disease that use indirect surrogate markers of disease. Cleerly’s AI-enabled approach for evaluating coronary computed tomography angiography (CCTA) allows physicians to more easily identify, characterize and quantify atherosclerosis (plaque) buildup in the walls of heart arteries.
NEW YORK-( BUSINESS WIRE )- Cleerly, the company creating a new standard of care for heart disease, and Heartbeat Health, the nation's largest virtual-first cardiovascular company, today announced a partnership to use precision heart health to more accurately determine cardiovascular risk and deliver better heart care. New alliance combines Cleerly’s AI-enabled approach to identifying early signs of heart disease with Heartbeat Health’s nationwide footprint of virtual cardiologists and care Therefore, the book can be considered as a benchmark publication of German speaking neurology around 1890 on migraine and it is highly recommended to present day headache and migraine researchers as well as historians of psychiatry and neurology.Cleerly partners with Heartbeat Health in new heart disease detection program Although Möbius's monograph on migraine lacks originality, it provides a concise, easy to understand and stylistically impressive overview on the state of knowledge at that time. Basically there were only few differences between the views of Möbius and his colleagues, the major dissimilarity being that Möbius postulated a merely suggestive impact but no physical effect of electrotherapy. Apart from a genetic factor and these cerebral changes, for Möbius the general state of health was a decisive factor and prevention and change in lifestyle therefore played a crucial role in his therapeutic recommendations. At the same time he made it clear that due to very limited diagnostic options this was only a hypothesis. As a representative of the central theory Möbius assumed that migraine was caused by aberrations in the brain. This study compares the monograph published by Möbius on the illness in 1894 with contemporary publications and with present day best practice to establish if the author really made an essential contribution to the problem of migraine. His impact on the development of knowledge on migraine has likewise been pointed to. Paul Julius Möbius (1853-1907), a Leipzig-based author and editor on a vast majority of subjects, has often been acknowledged as a leading 19th-century German neurologist.
0 kommentar(er)
